- ISIN
- US67079U1088
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Apr 4, 2022
Highlights
- EPS (TTM)
- $19.08
- PE Ratio
- 7.87
- PEG Ratio
- 0.06
- Total Revenue (TTM)
- $879.95M
- Gross Profit (TTM)
- $417.67M
- EBITDA (TTM)
- $275.94M
- Year Range
- $77.21 - $193.07
- Target Price
- $205.00
- ROA (TTM)
- 10.07%
- ROE (TTM)
- 21.80%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NUTX Performance Chart
Nutex Health Inc (NUTX) is down 8.8% since the beginning of the year. At $150 per share, NUTX is trading 22.2% below its 52-week high of $193.
Loading charts...
Returns By Period
Nutex Health Inc (NUTX) has returned -8.78% so far this year and 31.86% over the past 12 months.
Nutex Health Inc
- 1D
- -0.23%
- 1M
- 26.29%
- YTD
- -8.78%
- 6M
- -16.36%
- 1Y
- 31.86%
- 3Y*
- 30.28%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
NUTX Monthly Returns History
Based on dividend-adjusted daily data since Apr 4, 2022, NUTX's average daily return is +0.25%, while the average monthly return is +2.81%. At this rate, an investment would double in approximately 2.1 years.
Historically, 43% of months were positive and 57% were negative. The best month was Aug 2024 with a return of +168.9%, while the worst month was Jun 2022 at -67.7%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 7 months.
On a daily basis, NUTX closed higher 47% of trading days. The best single day was Apr 4, 2022 with a return of +282.8%, while the worst single day was Apr 5, 2022 at -33.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.62% | -25.76% | -13.96% | 25.42% | 8.31% | 16.31% | -8.78% | ||||||
| 2025 | 50.30% | 15.26% | -14.34% | 133.83% | 52.53% | -25.78% | -31.87% | -1.20% | 23.31% | 19.11% | -6.46% | 43.01% | 419.47% |
| 2024 | -27.78% | -13.08% | -15.13% | -57.94% | 12.81% | -12.84% | 33.72% | 168.89% | 1.45% | 2.72% | 66.89% | -14.81% | 17.37% |
| 2023 | -29.47% | 2.24% | -26.28% | -43.74% | -23.39% | -3.15% | -0.76% | -33.82% | -26.87% | 2.22% | -8.12% | -5.36% | -90.53% |
| 2022 | -9.86% | 5.94% | -67.69% | -18.14% | 1.89% | -44.24% | -46.33% | 92.55% | 22.58% | -81.82% |
Benchmark Metrics
Nutex Health Inc has an annualized alpha of 51.62%, beta of 1.64, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since April 04, 2022.
- This stock participated in 208.98% of S&P 500 Index downside but only 2.15% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 51.62%
- Beta
- 1.64
- R²
- 0.02
- Upside Capture
- 2.15%
- Downside Capture
- 208.98%
Return for Risk
Risk / Return Rank
NUTX ranks 56 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Nutex Health Inc (NUTX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUTX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.69 | ||
| Sortino ratioReturn per unit of downside risk | -1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.37 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 0.59 | 2.78 | -2.20 |
| Martin ratioReturn relative to average drawdown | 1.03 | 12.44 | -11.41 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Nutex Health Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Nutex Health Inc was 99.93%, occurring on Jul 9, 2024. The portfolio has not yet recovered.
The current Nutex Health Inc drawdown is 97.50%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -99.93%Jul 2024 | 2y 3mo | — | 4y 2moApr 2022 - now |
Drawdown Indicators
| NUTX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.93% | -56.78% | -43.15% |
Max Drawdown (1Y)Largest decline over 1 year | -54.32% | -9.10% | -45.22% |
Max Drawdown (3Y)Largest decline over 3 years | -93.95% | -18.90% | -75.05% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.50% | -1.80% | -95.70% |
Average DrawdownAverage peak-to-trough decline | -97.18% | -10.71% | -86.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.02% | 2.03% | +28.99% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Nutex Health Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Nutex Health Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NUTX, comparing it with other companies in the Health Information Services industry. Currently, NUTX has a P/E ratio of 7.9. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for NUTX compared to other companies in the Health Information Services industry. NUTX currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NUTX relative to other companies in the Health Information Services industry. Currently, NUTX has a P/S ratio of 0.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NUTX
Add Nutex Health Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NUTX